Modafinil Augmentation Therapy for Excessive Daytime Sleepiness and Negative Symptoms in Patients With Schizophrenia
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the effect of modafinil on the negative symptoms, such
as blunted affect and social withdrawal, of schizophrenic patients and to determine
modafinil's effect on excessive daytime sleepiness. A secondary purpose of the study is to
examine the effect of modafinil on cognitive functioning of schizophrenic patients.